OSE-2101 (EP-2101, Texopi, Tedopi) is under development for the treatment of non-small cell lung cancer, non-mucinous epithelial ovarian cancer and advanced or metastatic pancreatic ductal ...

Waukesha County Executive Paul Farrow says he's documenting and sharing his cancer journey in an effort to help others and is ...

Prexigebersen is under clinical development by Bio-Path and currently in Phase II for Relapsed Acute Myeloid Leukemia.

Background: The aim of the present study was to establish a predictive model to predict the peritoneal cancer index (PCI) preoperatively in patients with pseudomyxoma peritonei (PMP). Conclusion: This ...

Of the 67 cases, 27 cases (40.3%) were classified as the main duct type IPMT, 35 cases (52.2%) as the branch duct type IPMT, and five cases (7.5%) as the mixed duct type IPMT. There were 12 ...

In particular, higher age-standardized rates of serous carcinomas were reported in Europe. Mucinous carcinomas were associated with relatively higher age-standardized rates in many Asian countries ...